Matinas BioPharma Holdings MTNB
NYSE MTNB
$1.25 +0.01 (+0.81%)
As of: Nov 10, 2026 · 12:05 PM EST

Matinas BioPharma Holdings (MTNB) Acquisitions (2015)

Updated

Matinas BioPharma Holdings (MTNB) recorded Acquisitions of -$70,754 in FY2015.

Analysis

Matinas BioPharma Holdings (MTNB) Acquisitions (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -17.15 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 10.59 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Matinas BioPharma Holdings 525,307.18 -12.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 -70,754.00
API Access

Matinas BioPharma Holdings Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=MTNB&period=max&api_key=YOUR_API_KEY